UNSPSC 51202203: Methotrexate sodium

This classification denotes an antineoplastic antimetabolite, immunosuppressant, folic acid antagonist, and nucleic acid synthesis inhibitor with the molecular formula C20H20N8O5.2Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3IG1E710ZN, chemically known as glutamic acid, n-(p-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-, disodium salt, l-(+)- but more generally known as methotrexate sodium, which bears US NIH Compound Identifier 23893.

UNSPSC 51202203 Methotrexate sodium is a Commodity code that nominally names a specific immunosuppressant and antineoplastic drug; however, recent state and local opportunities show no procurement activity aligned with this pharmaceutical product itself. The three most recent opportunities tagged under this code—athletic training services for city fire and police departments (City of Tucson), general medical aid supplies for a fire rescue department (City of Tampa), and a direct-to-manufacturer prescription program research initiative (Texas Health and Human Services Commission)—are functionally unrelated to methotrexate sodium procurement and do not reflect purchasing patterns for this drug. The code appears to see little or no substantive state and local procurement activity for methotrexate sodium as a pharmaceutical commodity.

Without recent opportunities genuinely targeting methotrexate sodium or similar controlled pharmaceutical products, the geographic spread and issuing-body concentration remain unclear from current market signals. The three tagged opportunities span Texas, Arizona, and Florida across state health agencies and municipal fire departments, but they do not establish a meaningful pattern for this code itself. If you are pursuing methotrexate sodium supply or distribution to state and local health systems, hospitals, or public health agencies, this code's apparent inactivity signals either a mismatch between the code assignment and actual procurement channels or a genuinely quiet market segment that may route such purchases through group purchasing organizations, prime vendors, or federal health programs rather than direct state and local solicitations.